AQR Capital Management - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 178 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$1,849,000
+27.1%
91,733
+135.3%
0.00%0.0%
Q2 2021$1,455,000
-16.2%
38,992
-42.6%
0.00%0.0%
Q1 2021$1,736,000
+35.2%
67,873
+16.4%
0.00%
+50.0%
Q4 2020$1,284,000
-35.3%
58,306
-47.2%
0.00%
-33.3%
Q3 2020$1,985,000
-40.3%
110,366
-15.7%
0.00%
-40.0%
Q2 2020$3,326,000
+42.2%
130,943
+2.8%
0.01%
+25.0%
Q1 2020$2,339,000
+429.2%
127,331
+534.2%
0.00%
+300.0%
Q4 2019$442,000
+74.0%
20,079
+13.4%
0.00%
Q3 2019$254,000
-59.3%
17,707
-55.3%
0.00%
-100.0%
Q2 2019$624,000
+19.3%
39,643
+11.0%
0.00%0.0%
Q1 2019$523,000
-2.8%
35,724
-29.0%
0.00%0.0%
Q4 2018$538,000
-20.2%
50,281
+13.9%
0.00%0.0%
Q3 2018$674,000
+27.4%
44,161
+2.3%
0.00%0.0%
Q2 2018$529,000
+136.2%
43,178
+3.4%
0.00%
Q1 2016$224,000
-79.6%
41,758
-54.8%
0.00%
-100.0%
Q4 2015$1,097,000
+74.1%
92,440
+20.6%
0.00%
+100.0%
Q3 2015$630,000
+1.6%
76,678
+72.5%
0.00%0.0%
Q2 2015$620,00044,4590.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,813,392$67,676,00017.58%
Bain Capital Life Sciences Investors, LLC 3,080,237$114,954,0007.53%
RTW INVESTMENTS, LP 7,521,859$280,716,0004.24%
DAFNA Capital Management LLC 510,756$19,061,0003.99%
SILVERARC CAPITAL MANAGEMENT, LLC 229,892$8,580,0003.83%
Parkman Healthcare Partners LLC 304,686$11,371,0002.49%
Evolutionary Tree Capital Management, LLC 141,324$5,274,0002.43%
Eagle Health Investments LP 161,125$6,013,0002.06%
Lombard Odier Asset Management (Switzerland) SA 636,011$23,736,0001.20%
Woodline Partners LP 1,000,325$37,332,0000.70%
View complete list of DICERNA PHARMACEUTICALS INC shareholders